结果公布-话题@MedSci

#结果公布#

126篇内容 | 3397人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2004447, encodeId=2eb7200444eff, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=ESMO 2021：嘉和生物杰诺单抗治疗中国复发/难治原发性纵隔大B细胞淋巴瘤的Ⅱ期临床研究结果公布, objectType=article, longId=217412, objectId=6fdf21e412ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fdf21e412ed, replyNumber=0, likeNumber=97, createdTime=2022-09-06, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fdf21e412ed, moduleTitle=ESMO 2021：嘉和生物杰诺单抗治疗中国复发/难治原发性纵隔大B细胞淋巴瘤的Ⅱ期临床研究结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fdf21e412ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004439, encodeId=8756200443928, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=EuroIntervention：肾动脉超声消融治疗难治性高血压长期随访结果公布（RADIANCE-HTN SOLO研究）, objectType=article, longId=214815, objectId=a05f2148157b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a05f2148157b, replyNumber=0, likeNumber=0, createdTime=2022-02-04, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a05f2148157b, moduleTitle=EuroIntervention：肾动脉超声消融治疗难治性高血压长期随访结果公布（RADIANCE-HTN SOLO研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a05f2148157b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004429, encodeId=5bc52004429bf, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=胃癌一线免疫治疗III期研究中国亚组结果公布！, objectType=article, longId=209356, objectId=d45220935641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d45220935641, replyNumber=0, likeNumber=76, createdTime=2021-07-10, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d45220935641, moduleTitle=胃癌一线免疫治疗III期研究中国亚组结果公布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d45220935641)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004444, encodeId=298a20044442b, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=第五批国家组织药品集中采购61个药品中选结果公布，预计将于10月下旬在本市正式执行, objectType=article, longId=216519, objectId=4a2d216519c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a2d216519c2, replyNumber=0, likeNumber=82, createdTime=2022-03-30, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a2d216519c2, moduleTitle=第五批国家组织药品集中采购61个药品中选结果公布，预计将于10月下旬在本市正式执行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a2d216519c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004440, encodeId=ba2e20044405e, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布, objectType=article, longId=215078, objectId=585a2150e865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=585a2150e865, replyNumber=0, likeNumber=92, createdTime=2021-10-03, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=585a2150e865, moduleTitle=Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=585a2150e865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004446, encodeId=36a4200444681, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）, objectType=article, longId=217411, objectId=2e6921e411bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e6921e411bd, replyNumber=0, likeNumber=102, createdTime=2022-06-18, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e6921e411bd, moduleTitle=信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e6921e411bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004438, encodeId=efa62004438be, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）, objectType=article, longId=214041, objectId=ca9121404105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca9121404105, replyNumber=0, likeNumber=76, createdTime=2022-05-30, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca9121404105, moduleTitle=J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca9121404105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004448, encodeId=6866200444892, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=CHEST：慢性阻塞性肺病患者的肺动脉高压--COMPERA研究结果公布, objectType=article, longId=217933, objectId=a73721e93388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a73721e93388, replyNumber=0, likeNumber=0, createdTime=2021-10-10, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a73721e93388, moduleTitle=CHEST：慢性阻塞性肺病患者的肺动脉高压--COMPERA研究结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a73721e93388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004445, encodeId=d803200444546, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=ESMO 2021：特瑞普利单抗一线治疗食管癌的Ⅲ期临床研究结果公布，OS高达17个月, objectType=article, longId=217409, objectId=8a7b21e409e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a7b21e409e8, replyNumber=0, likeNumber=95, createdTime=2022-08-23, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a7b21e409e8, moduleTitle=ESMO 2021：特瑞普利单抗一线治疗食管癌的Ⅲ期临床研究结果公布，OS高达17个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a7b21e409e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004430, encodeId=1b1b2004430f6, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=第七次全国人口普查结果公布！新生儿出生大幅下降！创历史新低；60岁以上超2.6亿, objectType=article, longId=211128, objectId=bde5211128e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bde5211128e3, replyNumber=0, likeNumber=92, createdTime=2021-06-12, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bde5211128e3, moduleTitle=第七次全国人口普查结果公布！新生儿出生大幅下降！创历史新低；60岁以上超2.6亿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bde5211128e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004442, encodeId=0a88200444262, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=NEJM：辉瑞mRNA疫苗在医护人员中真实世界研究结果公布，完全接种疫苗后，哪些人会突破性感染？, objectType=article, longId=215384, objectId=25fc215384f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25fc215384f3, replyNumber=0, likeNumber=87, createdTime=2022-02-13, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25fc215384f3, moduleTitle=NEJM：辉瑞mRNA疫苗在医护人员中真实世界研究结果公布，完全接种疫苗后，哪些人会突破性感染？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25fc215384f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004437, encodeId=f6dd200443ead, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究, objectType=article, longId=213502, objectId=ee6b2135028f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee6b2135028f, replyNumber=0, likeNumber=92, createdTime=2021-09-13, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee6b2135028f, moduleTitle=SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee6b2135028f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004431, encodeId=5eb520044317f, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=第七次全国人口普查结果公布，老龄化将进一步加剧, objectType=article, longId=211137, objectId=4e9621113eb9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e9621113eb9, replyNumber=0, likeNumber=76, createdTime=2021-07-15, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e9621113eb9, moduleTitle=第七次全国人口普查结果公布，老龄化将进一步加剧, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e9621113eb9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004425, encodeId=8827200442555, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle= 拜耳Finerenone FIDELIO-DKD III期临床研究结果公布, objectType=article, longId=202599, objectId=ad7320259999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad7320259999, replyNumber=0, likeNumber=0, createdTime=2021-10-04, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad7320259999, moduleTitle= 拜耳Finerenone FIDELIO-DKD III期临床研究结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad7320259999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004436, encodeId=9d7020044362c, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=NEJM：开启医学新时代：体内CRISPR基因编辑临床试验结果公布，安全有效, objectType=article, longId=213372, objectId=036d2133e2b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=036d2133e2b0, replyNumber=0, likeNumber=80, createdTime=2022-02-23, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=036d2133e2b0, moduleTitle=NEJM：开启医学新时代：体内CRISPR基因编辑临床试验结果公布，安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=036d2133e2b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004434, encodeId=72ed200443418, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=II期BEYOND研究结果公布：罗特西普可改善成人非输血依赖性（NTD）β-地中海贫血生活质量, objectType=article, longId=212769, objectId=9e34212e69bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e34212e69bc, replyNumber=0, likeNumber=92, createdTime=2021-08-26, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e34212e69bc, moduleTitle=II期BEYOND研究结果公布：罗特西普可改善成人非输血依赖性（NTD）β-地中海贫血生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e34212e69bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004435, encodeId=93c52004435e0, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=Nat Commun：肌醇三磷酸酯治疗肝胆肿瘤患者的Ib期临床结果公布 , objectType=article, longId=213043, objectId=684821304392, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=684821304392, replyNumber=0, likeNumber=88, createdTime=2022-04-23, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=684821304392, moduleTitle=Nat Commun：肌醇三磷酸酯治疗肝胆肿瘤患者的Ib期临床结果公布 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=684821304392)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004432, encodeId=dd08200443259, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实, objectType=article, longId=211942, objectId=78d22119421d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78d22119421d, replyNumber=0, likeNumber=98, createdTime=2022-01-20, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d22119421d, moduleTitle=OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78d22119421d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004426, encodeId=d6a520044269a, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=国产新冠病毒灭活疫苗III期结果公布：保护率79.34%, objectType=article, longId=205472, objectId=2e462054e2ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e462054e2ce, replyNumber=0, likeNumber=79, createdTime=2021-02-02, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e462054e2ce, moduleTitle=国产新冠病毒灭活疫苗III期结果公布：保护率79.34%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e462054e2ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2004428, encodeId=32ba200442857, content=<a href='/topic/show?id=54ebe8621cf' target=_blank style='color:#2F92EE;'>#结果公布#</a>, objectTitle=NEJM：礼来Aβ抗体二期临床结果公布：达到主要终点，错失次要终点, objectType=article, longId=208386, objectId=c04f20838658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c04f20838658, replyNumber=0, likeNumber=88, createdTime=2021-08-28, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c04f20838658, moduleTitle=NEJM：礼来Aβ抗体二期临床结果公布：达到主要终点，错失次要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c04f20838658)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

结果公布

2020-05-29

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

ESMO 2021：嘉和生物杰诺单抗治疗中国复发/难治原发性纵隔大B细胞淋巴瘤的Ⅱ期临床研究结果公布

2022-09-06

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

EuroIntervention：肾动脉超声消融治疗难治性高血压长期随访结果公布（RADIANCE-HTN SOLO研究）

2022-02-04

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

胃癌一线免疫治疗III期研究中国亚组结果公布！

2021-07-10

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

第五批国家组织药品集中采购61个药品中选结果公布，预计将于10月下旬在本市正式执行

2022-03-30

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

Nature Medicine：重磅！晚期癌症患者100%治疗反应！88%完全缓解！双特异性靶点CAR-T疗法1期临床试验结果公布

2021-10-03

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）

2022-06-18

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

J Clin Oncol：新诊断的小儿T淋巴细胞性淋巴瘤多药化疗的长期安全性和有效性结果公布（COG AALL0434研究）

2022-05-30

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

CHEST：慢性阻塞性肺病患者的肺动脉高压--COMPERA研究结果公布

2021-10-10

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

ESMO 2021：特瑞普利单抗一线治疗食管癌的Ⅲ期临床研究结果公布，OS高达17个月

2022-08-23

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

第七次全国人口普查结果公布！新生儿出生大幅下降！创历史新低；60岁以上超2.6亿

2021-06-12

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

NEJM：辉瑞mRNA疫苗在医护人员中真实世界研究结果公布，完全接种疫苗后，哪些人会突破性感染？

2022-02-13

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

SoliMix结果公布：基础胰岛素与GLP-1RA的复方制剂与预混胰岛素的头对头比较研究

2021-09-13

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

第七次全国人口普查结果公布，老龄化将进一步加剧

2021-07-15

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

拜耳Finerenone FIDELIO-DKD III期临床研究结果公布

2021-10-04

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

NEJM：开启医学新时代：体内CRISPR基因编辑临床试验结果公布，安全有效

2022-02-23

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

II期BEYOND研究结果公布：罗特西普可改善成人非输血依赖性（NTD）β-地中海贫血生活质量

2021-08-26

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

Nat Commun：肌醇三磷酸酯治疗肝胆肿瘤患者的Ib期临床结果公布

2022-04-23

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

OCC 2021：Vascepa®中国临床三期研究结果公布：IPE在中国患者中的有效性和安全性得到进一步证实

2022-01-20

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

国产新冠病毒灭活疫苗III期结果公布：保护率79.34%

2021-02-02

shanyongle (审核中...)

前往app查看评论内容

#结果公布#

NEJM：礼来Aβ抗体二期临床结果公布：达到主要终点，错失次要终点

2021-08-28

科室
- - 订阅+
  - 更多科室
工具
服务